Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab

Ophthalmology

Volumn 120, Issue 1, 2013, Pages 160-168

  Bressler, Neil M ^a   Chang, Tom S ^b   Varma, Rohit ^c   Suñer, Ivan ^d   Lee, Paul ^e   Dolan, Chantal M ^f   Ward, James ^f   Ianchulev, Tsontcho ^g   Fine, Jennifer ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Retina Institute of California   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Retina Associates of Florida   (United States)

^e DUKE UNIVERSITY EYE CENTER   (United States)

^f GENENTECH INC   (United States)

^g Transcend Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VERTEPORFIN;

ARTICLE; CONTROLLED STUDY; DRIVING ABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OUTCOME ASSESSMENT; PERCEPTION; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SELF REPORT; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; AUTOMOBILE DRIVING; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SELF REPORT; SICKNESS IMPACT PROFILE; VISION, LOW; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84872050255     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.07.027     Document Type: Article

References (24)

1. J.D. Edwards, M. Perkins, L.A. Ross, S.L. Reynolds Driving status and three-year mortality among community-dwelling older adults J Gerontol A Biol Sci Med Sci 64 2009 300 305
2. S.J. Fonda, R.B. Wallace, A.R. Herzog Changes in driving patterns and worsening depressive symptoms among older adults J Gerontol B Psychol Sci Soc Sci 56 2001 S343 S351
3. E.J. Casson, L. Racette Vision standards for driving in Canada and the United States: a review for the Canadian Ophthalmological Society Can J Ophthalmol 35 2000 192 203
4. American Medical Association Physician's Guide to Assessing and Counseling Older Drivers 2nd ed. 2010 AMA Chicago http://www.ama-assn.org/ resources/doc/public-health/older-drivers-guide.pdf Accessed February 26, 2012
5. C. Owsley, G. McGwin Jr Vision impairment and driving Surv Ophthalmol 43 1999 535 550
6. R. Kington, D. Reuben, J. Rogowski, L. Lillard Sociodemographic and health factors in driving patterns after 50 years of age Am J Public Health 84 1994 1327 1329
7. N.M. Bressler Age-related macular degeneration is the leading cause of blindness JAMA 291 2004 1900 1901
8. A. Lotery, X. Xu, G. Zlatava, J. Loftus Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study Br J Ophthalmol 91 2007 1303 1307
9. M.T. Cahill, A.D. Banks, S.S. Stinnett, C.A. Toth Vision-related quality of life in patients with bilateral severe age-related macular degeneration Ophthalmology 112 2005 152 158
10. Submacular Surgery Trials Research Group Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4 Am J Ophthalmol 138 2004 91 108
11. Submacular Surgery Trials Research Group Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials report no. 5 Arch Ophthalmol 123 2005 78 88
12. G. Soubrane, A. Cruess, A. Lotery Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study Arch Ophthalmol 125 2007 1249 1254
13. A.T. Broman, B. Munoz, S.K. West Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER Invest Ophthalmol Vis Sci 42 2001 606 613
14. Submacular Surgery Trials Research Group Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization - SST report no. 1 Arch Ophthalmol 121 2003 531 539
15. C.M. Mangione, P.P. Lee, J. Pitts NEI-VFQ Field Test Investigators Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) Arch Ophthalmol 116 1998 1496 1504
16. C.M. Mangione Version 2000: the National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) http://www.nei.nih.gov/resources/visionfunction/ manual-cm2000.pdf Accessed December 14, 2010
17. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058
18. M.T. Cahill, S.S. Stinnett, A.D. Banks Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration Ophthalmology 112 2005 144 151
19. G.H. Berdeaux, J.P. Nordmann, E. Colin, B. Arnould Vision-related quality of life in patients suffering from age-related macular degeneration Am J Ophthalmol 139 2005 271 279
20. J.A. Sahel, F. Bandello, A. Augustin MICMAC Study Group Health-related quality of life and utility in patients with age-related macular degeneration Arch Ophthalmol 125 2007 945 951
21. D.M. Brown, M. Michels, P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
22. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
23. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
24. U.S. Department of Transportation Federal Motor Carrier Safety Administration. §391.41. Physical qualifications for drivers http://www.fmcsa.dot.gov/rules-regulations/administration/fmcsr/fmcsrruletext. aspx?reg=391.41 Accessed January 7, 2012